3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Gastrointestinal
2
Dermatologic
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Endocrine
1
CNS
1
Breast
1
Conditions
Somatostatinoma
2
Carcinoma, Islet Cell
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vipoma
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pituitary Neoplasms
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Nivolumab
2
Bortezomib
2
vatalanib
1
tovorafenib
1
tipifarnib
1
spartalizumab
1
sargramostim
1
romidepsin
1
pentetreotide
1
pasireotide
1
milademetan
1
fludarabine phosphate
1
entrectinib
1
entinostat
1
dabrafenib
1
cobimetinib
1
avelumab
1
alectinib
1
aldesleukin
1
Vemurafenib
1
Taxes
1
Specimen Handling
1
Rose Bengal
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
PLX8394
1
Molecular Diagnostic Techniques
1
Microscopy, Electron
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Melanoma
×
Biological Therapy
×
Endocrine
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled